HDinHD: Open Source Science for the HD Research Community
The goal of HDinHD is to foster and support a collaborative community united in its drive to accelerate the development of therapeutics that will delay the onset and/or ameliorate the effects of Huntington’s disease. HDinHD seeks to achieve this through:
- Sharing HD-related primary scientific data
- Sharing analyses and computational models built from HD-related scientific data
- Providing browsing and data interrogation tools over both primary and analyzed data that facilitate data exploration and hypothesis generation
- Building a forum for HD researchers to highlight their data, tools, know-how and insight to the community
The HDinHD website is currently a joint development effort by CHDI and UCLA, through the laboratory of Dr. Giovanni Coppola. As you will see when you Register for access, HDinHD highlights data and tools provided by the broader community. If you are interested in Contributing Data to HDinHD, suggest links to other HD-related scientific data or websites, or would otherwise like to provide Feedback to us, we encourage you to do so. HDinHD is for the community; please help us tailor and grow HDinHD in a direction that can make a difference to your research, and ultimately, to improve the lives of HD families.
Want to learn more about HDinHD?
Watch a detailed video overview of HDinHD presented at the 16th Annual HD Therapeutics Conference (April 2021). The video outlines data resources and tools within HDinHD and provides a detailed demonstration of the new HD Explorer tool. |
Read the following publication introducing HDinHD: HDinHD: A Rich Data Portal for Huntington’s Disease Research, J Huntingtons Dis., 10, 405-412
Latest news and publications from around the HD Ecosystem
HDBuzz
- 2024 HDBuzz Prize: Social Skills - The Hidden Gem in Improving Quality of Life for People with Huntington's disease?
- 2024 HDBuzz Prize: Thinking beyond therapies - it’s time to consider racial disparity in HD care and research
- Announcing the 2024 HDBuzz Prize for Young Science Writers!
- Bringing HD Treatments to Market: The Role of Regulatory Oversight
- Interruptions are encouraged
Literature
- UBE3A: Bridging the gap between neurodevelopment, neural function, and neurodegenerative woes
- Restoring Compromised Cl<sup>-</sup> in D2 Neurons of a HD Mouse Model Rescues Motor Disability
- Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway
- Direct observation of secondary nucleation in huntingtin amyloid formation by High-Speed Atomic Force Microscopy
- Mitochondrial dysfunction and inflammasome activation in neurodegenerative diseases: Mechanisms and therapeutic implications
News
- Teva's generics and biosimilars fuel another booming quarter - Fierce Pharma
- Winter's Onset Brings Mood Changes to Many Americans, Poll Finds - Brattleboro Reformer
- U.S. Diabetes Rates Rise to Nearly 1 in 6 Adults | Health | caledonianrecord.com
- Teva Pharmaceutical sees more growth in 2025 after strong Q3 - Reuters
- New ultrasensitive breath test can detect lung cancer early | Health | benningtonbanner.com